US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist

0.887
+0.041+4.84%

Close Nov 6 16:00 ET

111.10MMarket Cap-844P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

34.12%-19.45M

-49.81%-38.5M

-131.23%-43.73M

38.00%-92.72M

30.76%-18.59M

-4.09%-29.53M

26.88%-25.7M

68.06%-18.91M

-39.62%-149.55M

-205.37%-26.84M

Net income from continuing operations

7.05%-32.07M

172.91%23.79M

-9.48%-37.36M

13.43%-143.1M

-8.65%-41.84M

5.00%-34.51M

33.49%-32.63M

17.57%-34.13M

-33.20%-165.29M

-199.45%-38.51M

Operating gains losses

---4M

----

Depreciation and amortization

3.75%83K

9.64%91K

-70.69%85K

-14.65%530K

-31.86%77K

-56.04%80K

-44.30%83K

63.84%290K

-21.29%621K

-18.71%113K

Other non cash items

1,074.15%2.41M

647.06%1.4M

1.46%208K

54.43%820K

427.94%223K

0.99%205K

-6.50%187K

4.59%205K

-93.39%531K

-409.09%-68K

Change In working capital

1,808.74%10.48M

-685.90%-9.47M

-202.46%-10.72M

257.16%31.42M

218.01%18.79M

-48.31%549K

214.84%1.62M

140.93%10.46M

13.80%-19.99M

128.11%5.91M

-Change in receivables

210.17%6.22M

-336.75%-6.91M

-134.66%-4.12M

495.83%20.12M

8,219.26%10.96M

-42.25%-5.64M

92.99%2.92M

576.39%11.89M

47.13%-5.08M

96.40%-135K

-Change in inventory

-310.93%-1.2M

-556.13%-707K

-30.98%274K

1,100.85%1.18M

148.00%62K

172.79%567K

-61.63%155K

71.12%397K

91.93%-118K

132.47%25K

-Change in prepaid assets

-95.70%167K

202.14%565K

-338.45%-3.67M

215.43%6.67M

-51.62%1.06M

-43.51%3.89M

-74.73%187K

109.85%1.54M

76.65%-5.78M

110.08%2.2M

-Change in payables and accrued expense

182.84%5.54M

-52.88%-2.17M

5.89%-2.96M

151.95%4.35M

71.87%6.95M

309.41%1.96M

63.78%-1.42M

58.38%-3.14M

-163.78%-8.37M

-8.11%4.05M

-Change in other current assets

17.00%585K

17.50%564K

17.10%541K

16.99%1.96M

17.38%520K

17.37%500K

16.79%480K

16.37%462K

15.73%1.68M

15.67%443K

-Change in other current liabilities

-15.40%-832K

-15.08%-809K

-15.54%-788K

-24.01%-2.87M

-15.36%-766K

-27.39%-721K

-27.82%-703K

-27.24%-682K

-20.81%-2.32M

-29.94%-664K

Cash from discontinued investing activities

Operating cash flow

34.12%-19.45M

-49.81%-38.5M

-131.23%-43.73M

38.00%-92.72M

30.76%-18.59M

-4.09%-29.53M

26.88%-25.7M

68.06%-18.91M

-39.62%-149.55M

-205.37%-26.84M

Investing cash flow

Cash flow from continuing investing activities

197.25%7.47M

142.14%51.26M

167.74%21.94M

107.62%7.94M

141.11%26.84M

-165.84%-7.69M

157.85%21.17M

-130.77%-32.39M

-173.50%-104.26M

-312.21%-65.3M

Net PPE purchase and sale

--0

---195K

--0

44.34%-118K

--0

Net intangibles purchase and sale

----

--0

----

--0

----

Net investment purchase and sale

197.25%7.47M

142.14%51.26M

168.34%22.14M

107.62%7.94M

141.11%26.84M

-165.62%-7.69M

157.85%21.17M

-132.07%-32.39M

-170.58%-104.14M

-314.25%-65.3M

Cash from discontinued investing activities

Investing cash flow

197.25%7.47M

142.14%51.26M

167.74%21.94M

107.62%7.94M

141.11%26.84M

-165.84%-7.69M

157.85%21.17M

-130.77%-32.39M

-173.50%-104.26M

-312.21%-65.3M

Financing cash flow

Cash flow from continuing financing activities

-99.42%1.12M

-99.83%264K

163.06%193.74M

17,293.19%155.84M

Net issuance payments of debt

--0

----

--0

----

Net common stock issuance

----

--0

----

1,816.20%189.76M

--154.68M

Proceeds from stock option exercised by employees

--0

----

-71.74%1.12M

-77.32%264K

--0

----

6.19%3.98M

29.91%1.16M

Net other financing activities

--0

----

Cash from discontinued financing activities

Financing cash flow

--0

----

-99.42%1.12M

-99.83%264K

--0

----

163.06%193.74M

17,293.19%155.84M

Net cash flow

Beginning cash position

3.99%85.11M

-63.30%31.39M

-61.14%53.19M

-30.67%136.89M

-38.98%44.58M

-2.59%81.85M

-44.78%85.54M

-30.67%136.89M

121.55%197.45M

-47.98%73.06M

Current changes in cash

67.81%-11.98M

1,564.83%53.73M

57.53%-21.79M

-39.26%-83.66M

-86.62%8.52M

-241.48%-37.22M

94.79%-3.67M

-20.85%-51.3M

-155.43%-60.07M

11.48%63.7M

Effect of exchange rate changes

169.23%36K

57.69%-11K

64.44%-16K

93.03%-34K

-29.37%89K

25.71%-52K

94.27%-26K

50.00%-45K

-916.67%-488K

193.33%126K

End cash Position

64.12%73.17M

3.99%85.11M

-63.30%31.39M

-61.14%53.19M

-38.98%44.58M

-2.59%81.85M

-44.78%85.54M

-30.67%136.89M

Free cash flow

34.12%-19.45M

-49.81%-38.5M

-132.26%-43.92M

38.05%-92.72M

30.76%-18.59M

-3.95%-29.53M

26.88%-25.7M

68.10%-18.91M

-32.66%-149.67M

-204.17%-26.84M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	34.12%-19.45M	-49.81%-38.5M	-131.23%-43.73M	38.00%-92.72M	30.76%-18.59M	-4.09%-29.53M	26.88%-25.7M	68.06%-18.91M	-39.62%-149.55M	-205.37%-26.84M
Net income from continuing operations	7.05%-32.07M	172.91%23.79M	-9.48%-37.36M	13.43%-143.1M	-8.65%-41.84M	5.00%-34.51M	33.49%-32.63M	17.57%-34.13M	-33.20%-165.29M	-199.45%-38.51M
Operating gains losses	---4M	----	----	----	----	----	----	----	----	----
Depreciation and amortization	3.75%83K	9.64%91K	-70.69%85K	-14.65%530K	-31.86%77K	-56.04%80K	-44.30%83K	63.84%290K	-21.29%621K	-18.71%113K
Other non cash items	1,074.15%2.41M	647.06%1.4M	1.46%208K	54.43%820K	427.94%223K	0.99%205K	-6.50%187K	4.59%205K	-93.39%531K	-409.09%-68K
Change In working capital	1,808.74%10.48M	-685.90%-9.47M	-202.46%-10.72M	257.16%31.42M	218.01%18.79M	-48.31%549K	214.84%1.62M	140.93%10.46M	13.80%-19.99M	128.11%5.91M
-Change in receivables	210.17%6.22M	-336.75%-6.91M	-134.66%-4.12M	495.83%20.12M	8,219.26%10.96M	-42.25%-5.64M	92.99%2.92M	576.39%11.89M	47.13%-5.08M	96.40%-135K
-Change in inventory	-310.93%-1.2M	-556.13%-707K	-30.98%274K	1,100.85%1.18M	148.00%62K	172.79%567K	-61.63%155K	71.12%397K	91.93%-118K	132.47%25K
-Change in prepaid assets	-95.70%167K	202.14%565K	-338.45%-3.67M	215.43%6.67M	-51.62%1.06M	-43.51%3.89M	-74.73%187K	109.85%1.54M	76.65%-5.78M	110.08%2.2M
-Change in payables and accrued expense	182.84%5.54M	-52.88%-2.17M	5.89%-2.96M	151.95%4.35M	71.87%6.95M	309.41%1.96M	63.78%-1.42M	58.38%-3.14M	-163.78%-8.37M	-8.11%4.05M
-Change in other current assets	17.00%585K	17.50%564K	17.10%541K	16.99%1.96M	17.38%520K	17.37%500K	16.79%480K	16.37%462K	15.73%1.68M	15.67%443K
-Change in other current liabilities	-15.40%-832K	-15.08%-809K	-15.54%-788K	-24.01%-2.87M	-15.36%-766K	-27.39%-721K	-27.82%-703K	-27.24%-682K	-20.81%-2.32M	-29.94%-664K
Cash from discontinued investing activities
Operating cash flow	34.12%-19.45M	-49.81%-38.5M	-131.23%-43.73M	38.00%-92.72M	30.76%-18.59M	-4.09%-29.53M	26.88%-25.7M	68.06%-18.91M	-39.62%-149.55M	-205.37%-26.84M
Investing cash flow
Cash flow from continuing investing activities	197.25%7.47M	142.14%51.26M	167.74%21.94M	107.62%7.94M	141.11%26.84M	-165.84%-7.69M	157.85%21.17M	-130.77%-32.39M	-173.50%-104.26M	-312.21%-65.3M
Net PPE purchase and sale	--0	--0	---195K	--0	--0	--0	--0	--0	44.34%-118K	--0
Net intangibles purchase and sale	----	----	----	--0	----	----	----	----	--0	----
Net investment purchase and sale	197.25%7.47M	142.14%51.26M	168.34%22.14M	107.62%7.94M	141.11%26.84M	-165.62%-7.69M	157.85%21.17M	-132.07%-32.39M	-170.58%-104.14M	-314.25%-65.3M
Cash from discontinued investing activities
Investing cash flow	197.25%7.47M	142.14%51.26M	167.74%21.94M	107.62%7.94M	141.11%26.84M	-165.84%-7.69M	157.85%21.17M	-130.77%-32.39M	-173.50%-104.26M	-312.21%-65.3M
Financing cash flow
Cash flow from continuing financing activities	0			-99.42%1.12M	-99.83%264K	0			163.06%193.74M	17,293.19%155.84M
Net issuance payments of debt	--0	----	----	----	----	--0	----	----	----	----
Net common stock issuance	----	----	----	--0	----	----	----	----	1,816.20%189.76M	--154.68M
Proceeds from stock option exercised by employees	--0	----	----	-71.74%1.12M	-77.32%264K	--0	----	----	6.19%3.98M	29.91%1.16M
Net other financing activities	--0	----	----	----	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	--0	----	----	-99.42%1.12M	-99.83%264K	--0	----	----	163.06%193.74M	17,293.19%155.84M
Net cash flow
Beginning cash position	3.99%85.11M	-63.30%31.39M	-61.14%53.19M	-30.67%136.89M	-38.98%44.58M	-2.59%81.85M	-44.78%85.54M	-30.67%136.89M	121.55%197.45M	-47.98%73.06M
Current changes in cash	67.81%-11.98M	1,564.83%53.73M	57.53%-21.79M	-39.26%-83.66M	-86.62%8.52M	-241.48%-37.22M	94.79%-3.67M	-20.85%-51.3M	-155.43%-60.07M	11.48%63.7M
Effect of exchange rate changes	169.23%36K	57.69%-11K	64.44%-16K	93.03%-34K	-29.37%89K	25.71%-52K	94.27%-26K	50.00%-45K	-916.67%-488K	193.33%126K
End cash Position	64.12%73.17M	3.99%85.11M	-63.30%31.39M	-61.14%53.19M	-61.14%53.19M	-38.98%44.58M	-2.59%81.85M	-44.78%85.54M	-30.67%136.89M	-30.67%136.89M
Free cash flow	34.12%-19.45M	-49.81%-38.5M	-132.26%-43.92M	38.05%-92.72M	30.76%-18.59M	-3.95%-29.53M	26.88%-25.7M	68.10%-18.91M	-32.66%-149.67M	-204.17%-26.84M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data